7 Biosimilars Takeaways from ISPOR 2018

At the International Society for Pharmacoeconomics and Outcomes Research’s (ISPOR) 23rd Annual International Meeting in Baltimore, Maryland, researchers and speakers highlighted emerging trends in biosimilars. Here are 7 key takeaways from the conference.

Related Content:

Virtual ISPORConference

Follow-On Biologics Poised to Expand Global Health Care Access and Lower Costs

Yesintek Biosimilar Shows Comparable Efficacy, Lower Immunogenicity Than Stelara, Says Elena Wolff-Holz, MD

Oncology Biosimilars Cut Costs; Diabetes and Other Diseases Could Follow